| Patent No. | Patent Title: |
| 7390870 | Immune-enhancing peptides |
| 7371826 | Polypeptide variants with altered effector function |
| 7371825 | Anti-MCP-1 antibodies, compositions, methods and uses |
| 7365168 | Alteration of FcRn binding affinities or serum half-lives of anti... |
| 7364731 | Polypeptide variants |
| 7361740 | Alteration of FcRn binding affinities or serum half-lives of anti... |
| 7355008 | Identification and engineering of antibodies with variant Fc regi... |
| 7351803 | CD16A binding proteins and use for the treatment of immune disord... |
| 7342106 | Human antihuman MCP-1 antibody and antibody fragment thereof |
| 7335742 | Polypeptide variants with altered effector function |
| 7332581 | Polypeptide variants with altered effector function |
| 7323311 | Methods of obtaining a specific binding member that binds eotaxin |
| 7317087 | Members of the FC receptor homolog gene family (FCRH1-3, 6), rela... |
| 7317091 | Optimized Fc variants |
| 7314615 | IκB Kinase-β (IKKβ) binding antibodies and methods of using sa... |
| 7297775 | Polypeptide variants |
| 7276585 | Immunoglobulin variants outside the Fc region |
| 7250491 | Hemolytic active proteins and genes encoding the same |
| 7247709 | Mitogenic oxygenases |
| 7241450 | DNA sequence and recombinant production of a Gramineae allergen |
| 7217798 | Alteration of Fc-fusion protein serum half-lives by mutagenesis |
| 7217797 | Alteration of FcRn binding affinities or serum half-lives of anti... |
| 7198946 | Screening for agents effective in decreasing abnormal macrophages... |
| 7196177 | Antibody variable region of a monoclonal antibody against human t... |
| 7138496 | Human monoclonal antibodies against human CXCR4 |
| 7122637 | Polypeptide variants with altered effector function |
| 7109304 | Humanized anti-CD19 antibodies |
Celebrity Inventors 
PatentStorm News
